The term Inactive DUSP27 Activators suggests a class of compounds that interact with a protein referred to as DUSP27 that is, by default, in an inactive state. If we extrapolate based on the known dual-specificity phosphatases (DUSPs) family, DUSP27 would likely be an enzyme that has the ability to dephosphorylate both tyrosine and serine/threonine residues on its substrate proteins. In this speculative class, Inactive DUSP27 Activators would be designed to bind to this inactive phosphatase, catalyzing a change in its conformation or dynamics that results in an active enzyme. The chemical structures of these activators might be diverse, potentially including small molecules, peptides, or other biologically active substances that have been crafted to interact with specific domains of DUSP27, such as the phosphatase domain, without inducing enzymatic activity.
The discovery and development of these Inactive DUSP27 Activators would require an initial understanding of the DUSP27 protein's structure and mechanism of inactivation. Should the protein exist, researchers would need to delineate the inactive conformation of DUSP27 and identify any regulatory regions or interacting partners that maintain its inactivity. Potential activators might be identified through high-throughput screening of chemical libraries to find molecules that bind to and affect the conformation of DUSP27. Such molecules might act by disrupting interactions that stabilize the inactive state or by inducing a conformational shift that predisposes the enzyme toward an active state. Once candidate molecules are identified, their efficacy and specificity would need to be confirmed through a series of biochemical assays, which might include measuring binding affinity, analyzing the kinetics of conformational changes, and evaluating the impact on the phosphatase activity of DUSP27 in vitro.
Items 1 to 10 of 11 total
Mostrar:
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
As espécies reactivas de oxigénio, como o peróxido de hidrogénio, podem ativar as vias de resposta ao stress, potencialmente regulando a DUSP27 como um regulador de feedback. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $106.00 $765.00 | 3 | |
Induz stress celular e ativa as vias MAPK, o que poderia levar à indução da expressão de DUSP27 como parte da resposta. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Como ativador da PKC, o PMA pode modular as vias da MAPK e pode influenciar a expressão da DUSP27. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Como inibidor da MEK, que está a montante da MAPK, o U0126 poderia afetar a regulação de feedback das MAPKs e influenciar potencialmente a expressão de DUSP27. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inibe a síntese proteica e pode induzir respostas de stress celular que podem regular positivamente genes responsivos ao stress como o DUSP27. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Um glucocorticoide sintético que pode influenciar a expressão de genes e pode ter impacto na expressão de genes reguladores de MAPK como o DUSP27. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Apresenta propriedades anti-inflamatórias e pode modular as vias de sinalização que influenciam a expressão de genes como o DUSP27. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Um inibidor da síntese proteica que pode ativar proteínas quinases activadas pelo stress, influenciando potencialmente a expressão de DUSP27. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Um inibidor da p38 MAPK que poderia afetar a expressão de genes reguladores a jusante, como o DUSP27, dentro da via de sinalização MAPK. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Um inibidor da quinase c-Jun N-terminal (JNK), que poderia modular a cascata de sinalização MAPK e influenciar a expressão de DUSP27. | ||||||